Literature DB >> 28501289

Alcohol-Related Dementia: A Systemic Review of Epidemiological Studies.

Chin Cheng1, Chieh-Liang Huang1, Chia-Jui Tsai2, Po-Han Chou3, Chih-Chien Lin4, Chin-Kuo Chang5.   

Abstract

BACKGROUND: Alcohol-related dementia (ARD) is a heterogeneous long-term cognitive problem that can develop in the course of alcoholism. Current understanding of ARD remains limited.
METHODS: We conducted a systematic review to synthesize available data on the epidemiology of ARD, through searching the relevant studies in the PubMed, PsycINFO, and ALOIS. "Alcohol" and "dementia" were used as keywords.
RESULTS: We included articles published between January 1, 1991 and February 29, 2016, where language was not limited. Of the 9 identified articles, the prevalence of ARD ranged from 1.19/1000 in multiday admission patients residing in the United Kingdom to 25.6% in elderly clinic alcoholics from the United States. The proportion of ARD in early-onset dementia taken from 3 studies was approximately 10%, whereas only 1.28% in late-onset dementia taken from 1 study.
CONCLUSIONS: Considering the relatively high proportion of ARD in early-onset dementia and its potentially reversible course, future investigation into ARD is necessary.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Alcohol; Alcohol-related dementia; Cognition; Dementia; Health insurance research database

Mesh:

Year:  2017        PMID: 28501289     DOI: 10.1016/j.psym.2017.02.012

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  13 in total

Review 1.  Brain-behavior relations and effects of aging and common comorbidities in alcohol use disorder: A review.

Authors:  Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychology       Date:  2019-09       Impact factor: 3.295

2.  PARP inhibition in vivo blocks alcohol-induced brain neurodegeneration and neuroinflammatory cytosolic phospholipase A2 elevations.

Authors:  Dimitrios E Kouzoukas; Jennifer A Schreiber; Nuzhath F Tajuddin; Simon Kaja; Edward J Neafsey; Hee-Yong Kim; Michael A Collins
Journal:  Neurochem Int       Date:  2019-06-25       Impact factor: 3.921

3.  Increased Toll-like Receptor-MyD88-NFκB-Proinflammatory neuroimmune signaling in the orbitofrontal cortex of humans with alcohol use disorder.

Authors:  Ryan P Vetreno; Liya Qin; Leon G Coleman; Fulton T Crews
Journal:  Alcohol Clin Exp Res       Date:  2021-08-20       Impact factor: 3.928

Review 4.  Categorising a problem: alcohol and dementia.

Authors:  Gabriele Cipriani; Angelo Nuti; Cecilia Carlesi; Claudio Lucetti; Mario Di Fiorino; Sabrina Danti
Journal:  Acta Neurol Belg       Date:  2020-10-14       Impact factor: 2.396

Review 5.  [Early onset substance abuse disorders and addictive diseases in old age].

Authors:  Dirk K Wolter
Journal:  Z Gerontol Geriatr       Date:  2018-09-04       Impact factor: 1.281

Review 6.  Modifiable Risk Factors in Alzheimer Disease and Related Dementias: A Review.

Authors:  Rachel Litke; Lorena Cancino Garcharna; Salima Jiwani; Judith Neugroschl
Journal:  Clin Ther       Date:  2021-06-06       Impact factor: 3.637

Review 7.  Korsakoff's syndrome: a critical review.

Authors:  Nicolaas Jm Arts; Serge Jw Walvoort; Roy Pc Kessels
Journal:  Neuropsychiatr Dis Treat       Date:  2017-11-27       Impact factor: 2.570

Review 8.  Alcohol use and dementia: a systematic scoping review.

Authors:  Jürgen Rehm; Omer S M Hasan; Sandra E Black; Kevin D Shield; Michaël Schwarzinger
Journal:  Alzheimers Res Ther       Date:  2019-01-05       Impact factor: 6.982

9.  Protective Effects of Polydatin Against Dementia-Related Disorders.

Authors:  Kim San Tang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

10.  Alcohol Consumption, Drinking Patterns, and Cognitive Performance in Young Adults: A Cross-Sectional and Longitudinal Analysis.

Authors:  Henk Hendriks; Ondine van de Rest; Almar Snippe; Jasper Kieboom; Koen Hogenelst
Journal:  Nutrients       Date:  2020-01-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.